The decision to treat, the treatment choice, and when to end treatment are based on risk/benefit ratios (including the risk of not treating). In addition to the U.S. Food and Drug Administration (FDA)-approved drugs, many medications are used “off-label” to treat insomnia. In general, it is optimal when trying to identify the best treatment for a patient, to start with medications that have the lowest-risk profile, before moving to those with a greater potential for side effects.
The following sections describe:
- Sedating Antidepressants
- Other Agents to Treat Insomnia
- Over-the-Counter Medications